Anticoagulation for atrial fibrillation using claims data - bigger is not always better
J Interv Card Electrophysiol
.
2023 Apr;66(3):511-512.
doi: 10.1007/s10840-022-01267-0.
Epub 2022 Jul 29.
Authors
Gerald V Naccarelli
1
2
,
Mohammed Ruzieh
3
4
,
Kevin J Mills
3
4
Affiliations
1
Department of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA. gnaccarelli@pennstatehealth.psu.edu.
2
Penn State Heart and Vascular Institute, 500 University Drive, Room H1511, Hershey, PA, USA. gnaccarelli@pennstatehealth.psu.edu.
3
Department of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
4
Penn State Heart and Vascular Institute, 500 University Drive, Room H1511, Hershey, PA, USA.
PMID:
35902509
DOI:
10.1007/s10840-022-01267-0
No abstract available
Publication types
Editorial
MeSH terms
Anticoagulants / therapeutic use
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / surgery
Blood Coagulation
Humans
Stroke* / etiology
Stroke* / prevention & control
Substances
Anticoagulants